Glenmark Pharma Q2 Results : Co posts Rs 355 crore net profit on robust sales (...)
Glenmark Pharma reported Rs 340 crore net profit in Q2FY25 led by robust sales growth in India and Europe. The drugmaker reported a net loss of Rs 180 crore in the corresponding quarter of the previous year.
Site référencé: The Economic Times
The Economic Times
Defence stocks overheated, wait for correction : Deven Choksey
5/08/2025
Sawaliya Food Products IPO to open on August 7, price band set at Rs 114 - Rs 120
5/08/2025
MCX shares slip over 3% on profit booking after a sharp 5% rally on strong Q1 results
5/08/2025
Ather Energy shares tumble 5% even as Q1 net loss narrows 2%YoY. Should you buy ?
5/08/2025
Fund Manager Talk | Kotak's Rohit Tandon on beating the market with earnings momentum
5/08/2025
Laxmi India Finance IPO set for debut today. Check GMP ahead of listing
5/08/2025
